학술논문
Ulcerative injection site reaction after third COVID‐19 vaccine dose with mRNA‐1273.
Document Type
Article
Author
Source
Subject
*COVID-19 vaccines
*COVID-19
*BOOSTER vaccines
*INJECTIONS
*SJOGREN'S syndrome
*
*
*
*
Language
ISSN
1396-0296
Abstract
This delayed reaction is different from a local injection site reaction, characterized by local pain, redness, and swelling, usually observed the next few days after the injection. In mRNA-1273 Phase 3 trial, delayed (defined as occurring on or after day 8) injection site reactions were reported only in 0.8% of the participants after the first dose and in 0.2% after the second dose.1 Based on a case series of 414 patients with skin reactions to BNT162b2 and mRNA-1273 vaccines, the most common cutaneous reactions to mRNA-1273 were delayed large local reactions, followed by local injection site reactions, while no serious adverse event did develop. Dear Editor, With the advent of vaccines against COronaVIrus Disease 2019 (COVID-19), associated local skin reactions are now largely reported. [Extracted from the article]